Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV
Date:
01/01/2023
Citation:
Teles MS, Lushniak S, Po-Yu Chiang T, Bailey JR, Gebo KA, Karaba AH, Durand CM, Segev DL, Connolly CM, Werbel WA. Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV. J Acquir Immune Defic Syndr. 2023 Jan 1;92(1):e3-e6. doi: 10.1097/QAI.0000000000003112. PMID: 36476571; PMCID: PMC9743179.
Abstract
No abstract available